Barrington lowered the firm’s price target on Concentrix to $84 from $121 and keeps an Outperform rating on the shares following the fiscal Q1 report. The reduced target is due to being conservative given increased business risk, the analyst tells investors in a research note. The firm believes the Webhelp acquisition should represent meaningful cross-selling opportunities and views Concentrix shares as undervalued.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNXC:
- CNXC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Concentrix files to sell 13.17M shares of common stock for holders
- Concentrix Schedules Release of Fiscal First Quarter 2024 Financial Results and Webcast of Investor Conference Call
- Concentrix appoints Peterson as EVP, Chief Product Officer
- Concentrix Appoints Ryan Peterson as Executive Vice President and Chief Product Officer
